653 related articles for article (PubMed ID: 30784952)
41. Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway.
Rolová G; Skurtveit S; Gabrhelík R; Mravčík V; Odsbu I
Addict Sci Clin Pract; 2024 May; 19(1):37. PubMed ID: 38741162
[TBL] [Abstract][Full Text] [Related]
42. Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.
Vekaria V; Bose B; Murphy SM; Avery J; Alexopoulos G; Pathak J
Transl Psychiatry; 2021 May; 11(1):265. PubMed ID: 33941761
[TBL] [Abstract][Full Text] [Related]
43. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
Swartz JA; Franceschini D; Scamperle K
AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281
[TBL] [Abstract][Full Text] [Related]
44. The Prevalence of Traumatic Brain Injury Among People With Co-Occurring Mental Health and Substance Use Disorders.
McHugo GJ; Krassenbaum S; Donley S; Corrigan JD; Bogner J; Drake RE
J Head Trauma Rehabil; 2017; 32(3):E65-E74. PubMed ID: 27455436
[TBL] [Abstract][Full Text] [Related]
45. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders: findings from the "Psychiatric and Addictive Dual Disorder in Italy (PADDI)" Study.
Carrà G; Crocamo C; Borrelli P; Popa I; Ornaghi A; Montomoli C; Clerici M
Compr Psychiatry; 2015 Apr; 58():152-9. PubMed ID: 25591906
[TBL] [Abstract][Full Text] [Related]
46. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.
Short VL; Hand DJ; MacAfee L; Abatemarco DJ; Terplan M
J Subst Abuse Treat; 2018 Jun; 89():67-74. PubMed ID: 29706175
[TBL] [Abstract][Full Text] [Related]
47. The effect of post-traumatic stress disorder on the risk of developing prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III.
Hassan AN; Le Foll B; Imtiaz S; Rehm J
Drug Alcohol Depend; 2017 Oct; 179():260-266. PubMed ID: 28818717
[TBL] [Abstract][Full Text] [Related]
48. National trends of suicidal ideation and mental health services use among US adults with opioid use disorder, 2009-2020.
Na PJ; Bommersbach TJ; Petrakis IL; Rhee TG
EClinicalMedicine; 2022 Dec; 54():101696. PubMed ID: 36267498
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey.
Amin-Esmaeili M; Rahimi-Movaghar A; Sharifi V; Hajebi A; Radgoodarzi R; Mojtabai R; Hefazi M; Motevalian A
Addiction; 2016 Oct; 111(10):1836-47. PubMed ID: 27177849
[TBL] [Abstract][Full Text] [Related]
50. Risk profile and treatment needs of women in jail with co-occurring serious mental illness and substance use disorders.
Nowotny KM; Belknap J; Lynch S; DeHart D
Women Health; 2014; 54(8):781-95. PubMed ID: 25204664
[TBL] [Abstract][Full Text] [Related]
51. Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey.
Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
Drug Alcohol Depend; 2018 Jul; 188():119-125. PubMed ID: 29775955
[TBL] [Abstract][Full Text] [Related]
52. A multisite study of the prevalence of serious mental illness, PTSD, and substance use disorders of women in jail.
Lynch SM; Dehart DD; Belknap JE; Green BL; Dass-Brailsford P; Johnson KA; Whalley E
Psychiatr Serv; 2014 May; 65(5):670-4. PubMed ID: 24487481
[TBL] [Abstract][Full Text] [Related]
53. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
Kelly MM; Reilly E; Quiñones T; Desai N; Rosenheck R
Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
[TBL] [Abstract][Full Text] [Related]
54. Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.
Robertson AG; Easter MM; Lin HJ; Frisman LK; Swanson JW; Swartz MS
J Subst Abuse Treat; 2018 Mar; 86():17-25. PubMed ID: 29415846
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.
Chan YF; Dennis ML; Funk RR
J Subst Abuse Treat; 2008 Jan; 34(1):14-24. PubMed ID: 17574804
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of co-occurring substance use and other mental disorders in the Canadian population.
Rush B; Urbanoski K; Bassani D; Castel S; Wild TC; Strike C; Kimberley D; Somers J
Can J Psychiatry; 2008 Dec; 53(12):800-9. PubMed ID: 19087478
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and associated factors of common mental disorders among adult patients attending HIV follow up service in Harar town, Eastern Ethiopia: a cross-sectional study.
Motumma A; Negesa L; Hunduma G; Abdeta T
BMC Psychol; 2019 Feb; 7(1):11. PubMed ID: 30795804
[TBL] [Abstract][Full Text] [Related]
58. Use of substance abuse treatment services by persons with mental health and substance use problems.
Wu LT; Ringwalt CL; Williams CE
Psychiatr Serv; 2003 Mar; 54(3):363-9. PubMed ID: 12610245
[TBL] [Abstract][Full Text] [Related]
59. Opioid Use Disorder among Hospitalized Adults in North Carolina: Analysis from the 2000-2020 NC State Inpatient Database.
Alemu BT; Beydoun HA; Olayinka O; Harmer B; Brown AR
South Med J; 2024 May; 117(5):226-234. PubMed ID: 38701842
[TBL] [Abstract][Full Text] [Related]
60. Mental Health Conditions and Substance Use Disorders Among Youth Subsequently Diagnosed With Opioid Use Disorder or Opioid Poisoning.
Agbese E; Stein BD; Druss BG; Dick AW; Pacula RL; Leslie DL
J Addict Med; 2022 May-Jun 01; 16(3):357-359. PubMed ID: 34261890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
